Standout Papers

Tofacitinib for the treatment of ankylosing spondylitis:... 2017 2026 2020 2023 291
  1. Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study (2021)
    Atul Deodhar, Huji Xu et al. Annals of the Rheumatic Diseases
  2. Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials (2017)
    Stanley Cohen, Yoshiya Tanaka et al. Annals of the Rheumatic Diseases

Citation Impact

5 from Science/Nature 100 standout
Sub-graph 1 of 20

Citing Papers

Therapeutic advances in rheumatoid arthritis
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
9 intermediate papers

Works of Lisy Wang being referenced

Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
2014
Analysis of Infections and All‐Cause Mortality in Phase II, Phase III, and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
2014
and 7 more

Author Peers

Author Rheumatology Hematology Genetics Immunology Last Decade Papers Cites
Lisy Wang 1252 655 323 446 40 1.9k
Elisa Chisci 5 2 9 52 9 410
Alan R. McIntosh 3 36 6 76 38 1.1k
Qianpeng Han 1 2 3 39 11 327
Ya. V. Pirko 1 7 72 441
María Elena Cantú-Cárdenas 15 245

All Works

Loading papers...

Rankless by CCL
2026